Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Record Results for Willis Lease Finance Corporation in 2024
-
Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial
-
H World Group Limited Schedules Fourth Quarter and Full Year of 2024 Earnings Release on March 20, 2025
-
Synaptics Launches Ultra-Low-Power Wi-Fi/Bluetooth/802.15.4 Triple Combo SoC Family for Embedded Edge AI IoT
-
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Synaptics Extends Edge AI Portfolio with High-Performance Adaptive MCUs for Multimodal Context-Aware Computing
-
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
-
Yacht Club de Monaco: Primo Cup-UBS Trophy begins with new classes, wind, and spectacle
-
Invesco Ltd: Form 8.3 - American Axle & Manufacturing Holdings Inc; Public dealing disclosure
-
Beam Therapeutics Announces Pricing of Underwritten Offering
-
Nexus Industrial REIT Announces Fourth Quarter and Year End 2024 Financial Results
-
VIVUS Launches QSYMIA® in the United Arab Emirates
-
G2 Goldfields Significantly Increases Gold Resources at the Oko Project, Guyana
-
BEN Expands AI Offerings in Latin America and Europe with Vybroo and Grupo Siete
-
Beneficient Announces Agreement to Settle GWG Litigation
-
LexinFintech Holdings Ltd. to Report Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 18, 2025
-
Beam Therapeutics Announces Positive Initial Data for BEAM-302 in the Phase 1/2 Trial in Alpha-1 Antitrypsin Deficiency (AATD), Demonstrating First Ever Clinical Genetic Correction of a Disease-causin
-
KBR Awarded $85M Procurement as a Service Contract for Airfield Repair Kits with U.S. Air Force
-
Final terms for bonds to be listed 11th March 2025
-
Prepayments, Realkredit Danmark A/S
-
Orion to open new Biologics R&D Centre in Cambridge, UK in 2025 to support global growth strategy, considers reorganizing some work in Turku
-
Orion to open new Biologics R&D Centre in Cambridge, UK in 2025 to support global growth strategy, considers reorganizing some work in Turku
-
Preliminary data on early redemptions (prepayments)
-
Correction: Annual Financial Statements of Orkuveitan | Robust Growth and Solid Performance
-
Lánasjóður sveitarfélaga - Útboð LSS 39 0303 og LSS151155
-
With reference to the press release from ÍL Fund and the Ministry of Finance and Economic Affairs concerning the possible winding-up of ÍL Fund
-
DIFI Announced Launch of New Certification Program
-
Huize Holding Limited to Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025
-
EV Cargo Reports Strong 2024 Financial Results in Transformative Year
-
Alm. Brand A/S – Weekly report on share buybacks
-
Danske Bank share buy-back programme: transactions in week 10
-
Viridien Launches Senior Secured Notes Offering
-
Viridien Launches Senior Secured Notes Offering
-
Press release from ÍL Fund and the Ministry of Finance and Economic Affairs
-
Sydbank share buyback programme: transactions in week 10
-
Banco Comercial Português, S.A. informs about decision to early redeem in full the EUR450,000,000 Subordinated Fixed Rate Reset Notes due 27 March 2030 bond issue
-
Notification of manager’s and closely related parties’ transactions with shares in Schouw & Co.
-
Keeping Pace with Modern Regulations: DGQEX Secures U.S. SEC License
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
MoonFox Analysis | Scrambling to Integrate DeepSeek: The Education Industry Enters a New Stage of Deep AI Integration
-
Form 8.5 (EPT/RI)-De La Rue plc
-
Valo Therapeutics announces EUR 19m of investment funding and expanded clinical trials
-
Offer Update
-
Form 8.5 (EPT/RI)-Alliance Pharma plc
-
Share buyback programme – week 10
-
Crédit Agricole Assurances announces its intention to issue its first perpetual Restricted Tier 1 notes
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
